When.com Web Search

  1. Ads

    related to: zantac vs gaviscon dosage comparison reviews consumer reports

Search results

  1. Results From The WOW.Com Content Network
  2. Fate of most remaining Zantac lawsuits weighed by ... - AOL

    www.aol.com/news/fate-most-remaining-zantac...

    In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after NDMA was found in samples of the drug.

  3. Ranitidine - Wikipedia

    en.wikipedia.org/wiki/Ranitidine

    Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12]

  4. Ranitidine bismuth citrate - Wikipedia

    en.wikipedia.org/wiki/Ranitidine_bismuth_citrate

    In elderly patients with CC more than 25 ml / min, the dose is not changed. Dose changes in liver failure are not required, since ranitidine and bismuth are excreted mainly by the kidneys. H 2 -histamine receptor blockers should be taken 2 hours after taking itraconazole a or ketoconazole a to avoid a significant decrease in their absorption.

  5. Zantac settlements - Wikipedia

    en.wikipedia.org/wiki/Zantac_settlements

    The Los Angeles Times headlined "Public Faces Overdose of Similar Drug Names." [14] The market for Zantac [15] and its competitors was described in 2005 as 13.5 billion US dollars. [16] The product's problem was described by The New York Times as being "that a potential cancer-causing contaminant can build up in the drug when stored for long ...

  6. Delaware judge lets more than 70,000 Zantac lawsuits go forward

    www.aol.com/news/delaware-judge-lets-more-70...

    By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that ...

  7. Pfizer offers up to $250 million to settle Zantac cancer ...

    www.aol.com/news/pfizer-offers-250-million...

    (Reuters) -Pfizer will pay up to $250 million to settle more than 10,000 U.S. lawsuits over cancer risks associated with its discontinued heartburn drug Zantac, the Financial Times reported on ...